|
Market Closed -
Sao Paulo
16:06:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 36.23 BRL | +31.60% |
|
+19.93% | +10.39% |
| 11:12am | European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading | MT |
| 04:16am | BioNTech, neoantigens by proxy |  |
Company Valuation: BioNTech SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 54,749 | 34,159 | 22,698 | 26,387 | 19,497 | 23,861 | - | - |
| Change | - | -37.61% | -33.55% | 16.25% | -26.11% | 22.39% | - | - |
| Enterprise Value (EV) 1 | 53,358 | 20,496 | 11,253 | 16,879 | 12,356 | 12,493 | 13,831 | 14,422 |
| Change | - | -61.59% | -45.1% | 50% | -26.8% | 1.11% | 10.71% | 4.28% |
| P/E | 5.72x | 3.72x | 24.9x | -39.7x | -17.3x | -18.1x | -19.2x | -25.8x |
| PBR | 4.62x | 1.7x | 1.12x | - | 1.06x | 1.42x | 1.54x | 1.66x |
| PEG | - | -0.79x | -0.3x | 0x | -0.2x | -1x | 3.19x | 1x |
| Capitalization / Revenue | 2.89x | 1.97x | 5.94x | 9.59x | 6.79x | 13.2x | 12.9x | 10.4x |
| EV / Revenue | 2.81x | 1.18x | 2.95x | 6.14x | 4.31x | 6.91x | 7.5x | 6.28x |
| EV / EBITDA | 3.47x | 1.61x | 12.9x | -16.6x | -12.1x | -8.98x | -9.48x | -13.4x |
| EV / EBIT | 3.49x | 1.62x | 16.3x | -12.8x | -8.79x | -6.94x | -8.25x | -11.8x |
| EV / FCF | 72.5x | 1.55x | 2.41x | -69x | 44x | -7.16x | -7.11x | -8.43x |
| FCF Yield | 1.38% | 64.5% | 41.5% | -1.45% | 2.27% | -14% | -14.1% | -11.9% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 39.63 | 37.77 | 3.83 | -2.77 | -4.7 | -5.523 | -5.19 | -3.869 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 18,977 | 17,311 | 3,819 | 2,751 | 2,870 | 1,807 | 1,843 | 2,297 |
| EBITDA 1 | 15,359 | 12,766 | 873.8 | -1,016 | -1,022 | -1,392 | -1,458 | -1,076 |
| EBIT 1 | 15,284 | 12,643 | 690.4 | -1,314 | -1,405 | -1,800 | -1,676 | -1,220 |
| Net income 1 | 10,292 | 9,434 | 930.3 | -665.3 | -1,136 | -1,348 | -1,313 | -953 |
| Net Debt 1 | -1,391 | -13,663 | -11,445 | -9,508 | -7,141 | -11,369 | -10,031 | -9,439 |
| Reference price 2 | 226.68 | 140.56 | 95.48 | 110.06 | 81.08 | 99.85 | 99.85 | 99.85 |
| Nbr of stocks (in thousands) | 241,521 | 243,019 | 237,716 | 239,740 | 240,455 | 251,204 | - | - |
| Announcement Date | 3/30/22 | 3/27/23 | 3/20/24 | 3/10/25 | 3/10/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 22.11x | 7.75x | 15.8x | 1.34% | 73.96B | |
| 36.85x | 9.53x | 29.23x | 0.04% | 64.66B | |
| -79.06x | 14.77x | -71.24x | -.--% | 27.32B | |
| -17.19x | 6.91x | -8.97x | -.--% | 27.86B | |
| 32.87x | 6.47x | 17.14x | -.--% | 25.97B | |
| 27.08x | 5.08x | 17.06x | -.--% | 19.98B | |
| 51.97x | 19.21x | 38.91x | 0.29% | 17.84B | |
| -1000000x | 41.19x | -1441.61x | -.--% | 16.24B | |
| 16.61x | 4.92x | 11.49x | -.--% | 13.3B | |
| Average | -111,100.97x | 12.87x | -154.69x | 0.19% | 31.9B | |
| Weighted average by Cap. | -56,560.79x | 10.91x | -72.87x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BNTX Stock
- B1NT34 Stock
- Valuation BioNTech SE
Select your edition
All financial news and data tailored to specific country editions
